Skip to main content
Move the World.
plant based covid vaccine

Lead Image Courtesy of Medicago

Canadian biopharm company Medicago and pharmaceutical giant GlaxoSmithKline (GSK) are moving their plant-based COVID-19 vaccine into phase 3 trials.

"We are pleased to take the significant step of initiating the Phase 3 clinical trial at sites around the world," Medicago CEO and president Takashi Nagao said in a press release.

 "This brings us one step closer to delivering an important new COVID-19 vaccine and contributing to the global fight against the pandemic along with our partner GSK."

Initial testing of the vaccine began late last fall, after it was found to provoke the creation of antibodies that neutralize the virus. 

In February, the vaccine was granted FDA Fast Track designation — which allows for sped-up development and review of medicines aimed at medical emergencies.

Medicago's COVID-19 vaccine uses both a different form of production and a different form of target (known as an antigen) to goose the immune system.

Medicago's COVID-19 vaccine uses both a different form of production and a different form of target (known as an antigen) to goose the immune system.

Pfizer and Moderna's mRNA vaccines use the genetic code of the coronavirus's spike protein as an antigen, while Sinovac's vaccine uses killed or inactivated virus.

The Medicago vaccine uses "Coronavirus-Like-Particles" (CoVLPs) for its antigen. As their name suggests, these particles mimic viruses but lack any of the genetic material. The immune system should respond to them like viruses, even though they can't replicate or cause an infection.

These imitation viruses are created in the leaves of N. benthamiana, tobacco's Aussie relative, "where it reproduces as the plant grows, making more antigens that can be harvested from the plants," as our own Kristin Houser explained about another tobacco-based COVID-19 vaccine.

Because particles that just float around without doing anything don't look very much like an infection, the immune system often doesn't respond very strongly to them, so the vaccine is then paired up with an adjuvant — a compound meant to increase the immune reaction — from GSK. 

Like most other COVID-19 vaccines, the Medicago/GSK vaccine is administered in two doses.

The phase 3 trial will test the vaccine against a placebo, enrolling up to 30,000 people, beginning with healthy adults between 18 and 65 before moving on to 65+ and people with comorbidities. 

Starting in Canada and the U.S., the study is aiming to be held in eight more countries, pending regulatory approval, the release states.

While it seems like a niche field, Medicago's not alone in the plant-based coronavirus vaccine game, as British American Tobacco and iBio are also working on candidates.

Further along still are plant-based vaccines for flu, with Medicago's performing well in large clinical trials.

 We'd love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected]

Up Next

If you want to understand a problem, talk to the people working on solutions. Join us as we meet the people and explore the ideas on the frontlines of an unprecedented global response.

Public Health
Big Tobacco Announces "Breakthrough" in Plant-Based Coronavirus Vaccine
Plant-Based Coronavirus Vaccine
Public Health
Big Tobacco Announces "Breakthrough" in Plant-Based Coronavirus Vaccine
A plant-based coronavirus vaccine developed by a subsidiary of British American Tobacco is now undergoing pre-clinical testing.

A plant-based coronavirus vaccine developed by a subsidiary of British American Tobacco is now undergoing pre-clinical testing.

Coronavirus
Patients Report Sudden Hearing Loss From COVID-19
Hearing Loss From COVID-19
Coronavirus
Patients Report Sudden Hearing Loss From COVID-19
Patients are experiencing sudden hearing loss from COVID-19, but if caught early enough, doctors can prevent the problem from becoming permanent.

Patients are experiencing sudden hearing loss from COVID-19, but if caught early enough, doctors can prevent the problem from becoming permanent.

Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
nanobodies
Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Public Health
Wearables Can Detect Coronavirus Symptoms Early
Wearables that Detect Coronavirus Symptoms
Public Health
Wearables Can Detect Coronavirus Symptoms Early
A study involving more than 600 people found that the Oura Ring wearables can detect coronavirus symptoms 72 hours prior to onset with 90% accuracy.

A study involving more than 600 people found that the Oura Ring wearables can detect coronavirus symptoms 72 hours prior to onset with 90% accuracy.

Public Health
Why Is an Antigen Test a Big Deal for COVID-19?
Antigen Test
Public Health
Why Is an Antigen Test a Big Deal for COVID-19?
The FDA has issued its first emergency use authorization for a COVID-19 antigen test, a new type of test for diagnosing the coronavirus.

The FDA has issued its first emergency use authorization for a COVID-19 antigen test, a new type of test for diagnosing the coronavirus.

Public Health
It's Safe to Order Takeout During the Coronavirus Pandemic. Here's Why.
Order Takeout During the Coronavirus
Public Health
It's Safe to Order Takeout During the Coronavirus Pandemic. Here's Why.
Many experts agree that you can safely order takeout during the coronavirus pandemic — you just need to follow these steps.

Many experts agree that you can safely order takeout during the coronavirus pandemic — you just need to follow these steps.

Public Health
Bill Gates Is Spending Billions to Produce 7 Coronavirus Vaccines
coronavirus vaccines
Public Health
Bill Gates Is Spending Billions to Produce 7 Coronavirus Vaccines
The Gates Foundation is building factories to manufacture seven promising coronavirus vaccines to prepare for mass production if any prove effective.

The Gates Foundation is building factories to manufacture seven promising coronavirus vaccines to prepare for mass production if any prove effective.

Autonomous Cars
Delivery Robot Distributes Supplies During Coronavirus
delivery robot
Autonomous Cars
Delivery Robot Distributes Supplies During Coronavirus
Chinese company Neolix’s delivery robot has proven to be an instrumental — and versatile — weapon in China’ fight against the novel coronavirus.

Chinese company Neolix’s delivery robot has proven to be an instrumental — and versatile — weapon in China’ fight against the novel coronavirus.

Public Health
A Smart Thermometer Is Helping Fight the Coronavirus
fight the coronavirus
Public Health
A Smart Thermometer Is Helping Fight the Coronavirus
Kinsa Health is helping fight the coronavirus by sharing data collected by its smart thermometers as quickly as possible.

Kinsa Health is helping fight the coronavirus by sharing data collected by its smart thermometers as quickly as possible.